Castle Biosciences, Inc. Common Stock (CSTL) is a publicly traded Healthcare sector company. As of May 21, 2026, CSTL trades at $20.00 with a market cap of $585.97M and a P/E ratio of -23.44. CSTL moved +4.35% today. Year to date, CSTL is -48.64%; over the trailing twelve months it is +21.39%. Its 52-week range spans $14.59 to $44.28. Analyst consensus is strong buy with an average price target of $44.40. Rallies surfaces CSTL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own CSTL include Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Castle Biosciences, Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $20.00 |
| Market Cap | $585.97M |
| P/E Ratio | -23.44 |
| EPS | $-0.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $44.28 |
| 52-Week Low | $14.59 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $344.23M |
| Net Income | $-24.16M |
| Gross Margin | 79.37% |
5 analysts cover CSTL: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $44.40.